Abstract:Diabetes belongs to a group of metabolic disorders characterized by long term high blood glucose levels due to either inadequate production of insulin (Type 1 diabetes, T1DM) or poor response of the recipient cell to insulin (Type 2 diabetes, T2DM). Organ dysfunctions are the main causes of morbidity and mortality due to high glucose levels. Understanding the mechanisms of organ crosstalk may help us improve our basic knowledge and find novel strategies to better treat the disease. Exosomes are part of a newly emerged research area and have attracted a great deal of attention for their capacity to regulate communications between cells. In conditions of diabetes, exosomes play important roles in the pathological processes in both T1DM and T2DM, such as connecting the immune cell response to pancreatic tissue injury, as well as adipocyte stimulation to insulin resistance of skeletal muscle or liver. Furthermore, in recent years, nucleic acids containing exosomes—especially microRNAs (miRNAs) and long noncoding RNAs (lncRNAs)—have been shown to mainly regulate communications between organs in pathological processes of diabetes, including influencing metabolic signals and insulin signals in target tissues, affecting cell viability, and modulating inflammatory pancreatic cells. Moreover, exosome miRNAs show promise in their use as biomarkers or in treatments for diabetes and diabetic complications. Thus, this paper summarizes the recent work on exosomes related to diabetes as well as the roles of exosomal miRNAs and lncRNAs in diabetic pathology and diagnosis in order to help us better understand the exact roles of exosomes in diabetes development.

Researches on the Mechanism of Exosomes in Diabetes Mellitus

[Exosomes and Their Roles in Diabetes Mellitus and Its Complications: from Pathogenic, Diagnostic and Therapeutical Perspectives].

The Immunomodulatory effect of exosomes in diabetes: a novel and attractive therapeutic tool in diabetes therapy

Exosomes and Their Noncoding RNA Cargo Are Emerging as New Modulators for Diabetes Mellitus

The Utility of Exosomes in Diagnosis and Therapy of Diabetes Mellitus and Associated Complications

How does exosome cause diabetes?

Exosomes as Emerging Regulators of Immune Responses in Type 2 Diabetes Mellitus

Exosomes from β-cells alleviated hyperglycemia and enhanced angiogenesis in islets of streptozotocin-induced diabetic mice.

Exosomes:their extraction and its research progress in the diagnosis and treatment of diabetic nephropathy

The role of exosome derived miRNAs in inter-cell crosstalk among insulin-related organs in type 2 diabetes mellitus

Exosomes for diabetes syndrome: ongoing applications and perspective

Exosomes and Macrophages: Bidirectional Mutual Regulation in the Treatment of Diabetic Complications

Exosomes and Obesity-Related Insulin Resistance

Emerging roles of exosomal miRNAs in diabetes mellitus

The role of exosomes and exosomal microRNA in diabetic cardiomyopathy

Exosomes derived from mesenchymal stem cells in diabetes and diabetic complications

Exosome-Like Vesicles as New Mediators and Therapeutic Targets for Treating Insulin Resistance and β-Cell Mass Failure in Type 2 Diabetes Mellitus

Emerging Roles Of Exosomes In T1dm

Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications

The roles of mesenchymal stem cell-derived exosomes in diabetes mellitus and its related complications

Exosomes in Action: Unraveling Their Role in Autoimmune Diseases and Exploring Potential Therapeutic Applications